|
Volume
18 Number 6
30 June 2016
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
18, Year 2016 >
Number 6, 30 June
|
|
|
|
|
|
Cloughesy
TF, Landolfi J, Hogan DJ, Bloomfield S, Carter B, Chen CC, Elder
JB, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T,
Nghiemphu PL, Piccioni D, Walbert T, Chu A, Das A, Diago OR,
Gammon D, Gruber HE, Hanna M, Jolly DJ, Kasahara N, McCarthy D,
Mitchell L, Ostertag D, Robbins JM, Rodriguez-Aguirre M, Vogelbaum
MA.
Phase
1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for
recurrent high-grade glioma.
Sci
Transl Med. 2016 Jun 1, 2016;8(341):341ra75→.
doi: 10.1126/scitranslmed.aad9784→.
PMID: 27252174→.
Interventional
study. ˍ
|
|
|
|
Zhang
I, Knisely JP.
Tumor-Treating
Fields-A Fundamental Change in Locoregional Management for
Glioblastoma.
JAMA
Oncol. 2016 Jun 1;2(6):813-4→.
doi: 10.1001/jamaoncol.2016.0081→.
PMID:
26986446→.
Interventional
study. ˍ
|
|
|
|
Botturi
A, Silvani A, Pravettoni G, Paoli RA, Lucchiari C.
Reversible
Valproate Induced Pisa Syndrome and Parkinsonism in a
Neuro-Oncology Patient with Depression and Epilepsy.
Case
Rep Neurol. 2016 Jun 6, 2016;8(2):115-9→.
doi: 10.1159/000446643→.
PMID: 27462241→.
Case
report. ˍ
|
|
|
|
Wang
J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DI, Zairis S,
Abate F, Liu Z, Elliott O, Shin YJ, Lee JK, Lee IH, Park WY, Eoli
M, Blumberg AJ, Lasorella A, Nam DH, Finocchiaro G, Iavarone A,
Rabadan R.
Clonal
evolution of glioblastoma under therapy.
Nat
Genet. 2016 Jun 6, 2016;48(7):768-76→.
doi: 10.1038/ng.3590→.
PMID: 27270107→.
Laboratory investigation. ˍ
|
|
|
|
Chamberlain
MC.
Treatment
for Patients With Newly Diagnosed Glioblastoma.
JAMA.
2016 Jun 7;315(21):2348→.
doi: 10.1001/jama.2016.1844→.
PMID: 27272590→.
Comment.
ˍ
Refers
to: Stupp
R, ei al., Maintenance Therapy With Tumor-Treating Fields Plus
Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized
Clinical Trial.
JAMA. 2015 Dec 15;314(23):2535-43→.
doi: 10.1001/jama.2015.16669→.
PMID: 26670971→.
Interventional study. ˍ
Author’s
reply: Stupp
R, et al., Treatment for Patients With Newly Diagnosed
Glioblastoma—Reply.
JAMA. 2016 Jun 7;315(21):2348-9→.
doi: 10.1001/jama.2016.1847→.
PMID: 27272591→.
Comment. ˍ
|
|
|
|
Stupp
R, Toms SA, Kesari S.
Treatment
for Patients With Newly Diagnosed Glioblastoma--Reply.
JAMA.
2016 Jun 7;315(21):2348-9→.
doi: 10.1001/jama.2016.1847→.
PMID: 27272591→.
Comment. ˍ
Refers
to: Chamberlain
MC., Treatment for Patients With Newly Diagnosed
Glioblastoma.
JAMA. 2016 Jun 7;315(21):2348→.
doi: 10.1001/jama.2016.1844→.
PMID: 27272590→.
Comment.
ˍ
In
turn referring
to: Stupp
R, ei al., Maintenance Therapy With Tumor-Treating Fields Plus
Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized
Clinical Trial.
JAMA. 2015 Dec 15;314(23):2535-43→.
doi: 10.1001/jama.2015.16669→.
PMID: 26670971→.
Interventional study. ˍ
|
|
|
|
Ryskeldiyev
N, Olenbay G, Auezova R, Killeen T, Aldiyarova N, Akhmetzhanova Z,
Cesnulis E, Akshulakov S.
Brain
Tumor in an In Vitro Fertilization-Facilitated Pregnancy: Fourth
Ventricle Anaplastic Ependymoma in the Second Trimester.
J
Neurol Surg Rep. 2016 Jun 9;77(2):e86-8→.
doi: 10.1055/s-0036-1583311→.
PMID: 27330925→.
Case report. ˍ
|
|
|
|
Rios
A, Hsu SH, Blanco A, Buryanek J, Day AL, McGuire MF, Brown RE.
Durable
response of glioblastoma to adjuvant therapy consisting of
temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4
inhibitor, together with lapatinib, metformin and
niacinamide.
Oncoscience.
2016 Jun 11;3(5-6):156-63→.
doi: 10.18632/oncoscience.311→.
PMID: 27489862→.
Case
report. ˍ
|
|
|
|
Okolie
O, Bago JR, Schmid RS, Irvin DM, Bash RE, Miller CR, Hingtgen SD.
Reactive
astrocytes potentiate tumor aggressiveness in a murine glioma
resection and recurrence model.
Neuro
Oncol. 2016 Jun 13, 2016;18(12):1622-1633→.
doi: 10.1093/neuonc/now117→.
PMID: 27298311→.
Laboratory investigation. ˍ
|
|
|
|
Nazarian J, Mason GE, Ho CY, Panditharatna E, Kambhampati M,
Vezina LG, Packer RJ, Hwang EI.
Histological
and molecular analysis of a progressive diffuse intrinsic pontine
glioma and synchronous metastatic lesions: a case
report.
Oncotarget.
2016 Jun
14;7(27):42837-42842→.
doi: 10.18632/oncotarget→.10034.
PMID: 27329600→.
Case report. ˍ
|
|
|
|
Raizer
JJ, Chandler JP, Ferrarese R, Grimm SA, Levy RM, Muro K, Rosenow
J, Helenowski I, Rademaker A, Paton M, Bredel M.
A
phase II trial evaluating the effects and intra-tumoral
penetration of bortezomib in patients with recurrent malignant
gliomas.
J
Neurooncol. 2016 Jun 14, 2016;129(1):139-46→.
doi: 10.1007/s11060-016-2156-3→.
PMID: 27300524→.
Interventional study. ˍ
|
|
|
|
Zhou
X, Liao X, Zhang B, He H, Shui Y, Xu W, Jiang C, Shen L, Wei Q.
Recurrence
patterns in patients with high-grade glioma following
temozolomide-based chemoradiotherapy.
Mol
Clin Oncol. 2016 Jun 15. 2016;5(2):289-294→.
doi: 10.3892/mco.2016.936→.
PMID: 27446566→.
Observational
study. ˍ
|
|
|
|
Sagberg LM, Drewes C, Jakola AS,
Solheim O.
Accuracy
of operating neurosurgeons' prediction of functional levels after
intracranial tumor surgery.
J
Neurosurg. 2016 Jun 17, 2017;126(4):1173-1180→.
doi: 10.3171/2016.3.JNS152927→.
PMID:
27315026→.
Interventional
study.
ˍ
|
|
|
|
Tini
P, Pirtoli L.
Combining
Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and
Effective?
Clin
Oncol (R Coll Radiol). 2016 Jun 18, 2016;28(10):663→.
doi: 10.1016/j.clon.2016.06.003→.
PMID: 27329252→.
Comment.
ˍ
Refers
to: Carter
T, et al., Ipilimumab and Bevacizumab in Glioblastoma.
Clin
Oncol (R Coll Radiol). 2016 May 8, 2016 Oct;28(10):622-626→.
doi: 10.1016/j.clon.2016.04.042→.
PMID: 27169593→.
Interventional study. ˍ
|
|
|
|
Hajri
R, Dunet V, Prior JO.
Glioblastoma
Multiforme Recurrence.
Radiology.
2016 Jun 20, 2016;280(1):326-7→.
doi: 10.1148/radiol.2016152881→.
PMID: 27322981→.
Comment.
ˍ
Refers
to: Iagaru
A, et al., Glioblastoma Multiforme Recurrence: An Exploratory
Study of (18)F FPPRGD2 PET/CT.
Radiology. 2015 May 12,
2015;277(2):497-506→.
doi: 10.1148/radiol.2015141550→.
PMID: 25965900→.
Interventional
study. ˍ
|
|
|
|
Iagaru
A, Mosci C, Mittra E, Zaharchuk G, Fischbein N, Harsh G, Li G,
Nagpal S, Recht L, Gambhir SS.
Glioblastoma
Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2
PET/CT.
(Erratum)
Radiology.
2016 Jun 20, 2016;280(1):328→.
doi: 10.1148/radiol.2016164020→.
PMID:
27322985→.
Correction. ˍ
Refers
to: Iagaru
A, et al., Glioblastoma Multiforme Recurrence: An Exploratory
Study of (18)F FPPRGD2 PET/CT.
Radiology. 2015 May 12,
2015;277(2):497-506→.
doi: 10.1148/radiol.2015141550→.
PMID: 25965900→.
Interventional
study. ˍ
|
|
|
|
Bale
TA, Abedalthagafi M, Bi WL, Kang YJ, Merrill P, Dunn IF, Dubuc A,
Charbonneau SK, Brown L, Ligon AH, Ramkissoon SH, Ligon KL.
Genomic
characterization of recurrent high-grade astroblastoma.
Cancer
Genet. 2016 Jun 21, 2016;209(7-8):321-30→.
doi: 10.1016/j.cancergen.2016.06.002→.
PMID: 27425854→.
Laboratory
investigation. ˍ
|
|
|
|
Cicone
F, Clerico A, Minniti G, Paiano M, Carideo L, Scaringi C, Langen
KJ, Scopinaro F.
18F-DOPA
PET in medulloblastoma: two Case report.
World
Neurosurg. 2016 Jun 21, 2016;93:490.e7-490.e11→.
doi: 10.1016/j.wneu.2016.06.058→.
PMID: 27354292→.
Case
report. ˍ
|
|
|
*
|
Lasocki
A, Gaillard F, Tacey M, Drummond K, Stuckey S.
Multifocal
and multicentric glioblastoma: Improved characterisation with
FLAIR imaging and prognostic implications.
J
Clin Neurosci. 2016 Jun 21, 2016;31:92-8→.
doi: 10.1016/j.jocn.2016.02.022→.
PMID: 27343042→.
Observational
study. ˍ
|
|
|
|
Pérez-Beteta
J, Martínez-González A, Molina D, Amo-Salas M, Luque
B, Arregui E, Calvo M, Borrás JM, López C,
Claramonte M, Barcia JA, Iglesias L, Avecillas J, Albillo D,
Navarro M, Villanueva JM, Paniagua JC, Martino J, Velásquez
C, Asenjo B, Benavides M, Herruzo I, Delgado MD, Del Valle A,
Falkov A, Schucht P, Arana E, Pérez-Romasanta L,
Pérez-García VM.
Glioblastoma:
does the pre-treatment geometry matter? A postcontrast T1
MRI-based study.
Eur
Radiol. 2016 Jun 21, 2017;27(3):1096-1104→.
doi: 10.1007/s00330-016-4453-9→.
PMID: 27329522→.
Observational study. ˍ
|
|
|
|
Simonetti
G, Gaviani P, Lamperti E, Innocenti A, Botturi A, Saini M, Pollo
B, Silvani A.
A
case of medulloblastoma in adult patient affected by anaplastic
oligoastrocytoma.
Neurol
Sci. 2016 Jun 21, 2016;37(10):1727-30→.
doi: 10.1007/s10072-016-2640-8→.
PMID: 27329275→.
Case report. ˍ
|
|
|
|
Adeberg
S, Harrabi SB, Bougatf N, Bernhardt D, Rieber J, Koerber SA, Syed
M, Sprave T, Mohr A, Abdollahi A, Haberer T, Combs SE, Herfarth K,
Debus J, Rieken S.
Intensity-modulated
proton therapy, volumetric-modulated arc therapy, and 3D conformal
radiotherapy in anaplastic astrocytoma and glioblastoma : A
dosimetric comparison.
Strahlenther
Onkol. 2016 Jun 22, 2016;192(11):770-779→.
doi: 10.1007/s00066-016-1007-7→.
PMID: 27334276→.
Observational study. ˍ
|
|
|
|
Espinoza
JC, Haley K, Patel N, Dhall G, Gardner S, Allen J, Torkildson J,
Cornelius A, Rassekh R, Bedros A, Etzl M, Garvin J, Pradhan K,
Corbett R, Sullivan M, McGowage G, Stein D, Jasty R, Sands SA, Ji
L, Sposto R, Finlay JL.
Outcome
of young children with high-grade glioma treated with
irradiation-avoiding intensive chemotherapy regimens: Final report
of the Head Start II and III trials.
Pediatr
Blood Cancer. 2016 Jun 22, 2016;63(10):1806-13→.
doi: 10.1002/pbc.26118→.
PMID: 27332770→.
Interventional study. ˍ
|
|
|
|
Shoji
T, Saito R, Kanamori M, Sonoda Y, Watanabe M, Tominaga T.
Sarcoma-like
tumor originating from oligodendroglioma.
Brain
Tumor Pathol. 2016 Jun 22, 2016;33(4):255-260→.
doi: 10.1007/s10014-016-0268-2→.
PMID: 27333891→.
Case report. ˍ
|
|
|
|
Tacik
P, Curry S, Fujioka S, Strongosky A, Uitti RJ, van Gerpen JA,
Diehl NN, Heckman MG, Wszolek ZK.
Cancer
in Parkinson's disease.
Parkinsonism
Relat Disord. 2016 Jun 22, 2016;31:28-33→.
doi: 10.1016/j.parkreldis.2016.06.014→.
PMID: 27372241→.
Observational study. ˍ
|
|
|
|
Dützmann
S, Schiborr C, Kocher A, Pilatus U, Hattingen E, Weissenberger J,
Geßler F, Quick-Weller J, Franz K, Seifert V, Frank J, Senft
C.
Intratumoral
Concentrations and Effects of Orally Administered Micellar
Curcuminoids in Glioblastoma Patients.
Nutr
Cancer. 2016 Jun 24, 2016;68(6):943-8→.
doi: 10.1080/01635581.2016.1187281→.
PMID: 27340742→.
Interventional study. ˍ
|
|
|
|
Salloum
R, Hummel TR, Kumar SS, Dorris K, Li S, Lin T, Daryani VM, Stewart
CF, Miles L, Poussaint TY, Stevenson C, Goldman S, Dhall G, Packer
R, Fisher P, Pollack IF, Fouladi M, Boyett J, Drissi R.
A
molecular biology and phase II study of imetelstat (GRN163L) in
children with recurrent or refractory central nervous system
malignancies: a pediatric brain tumor consortium study.
J
Neurooncol. 2016 Jun 27, 2016;129(3):443-451→.
doi: 10.1007/s11060-016-2189-7→.
PMID: 27350411→.
Interventional study: ˍ
ˍ
|
|
|
|
Mota
Ferreira L, Gehrcke M, Ferrari Cervi V, Eliete Rodrigues
Bitencourt P, Ferreira da Silveira E, Hofstatter Azambuja J,
Prates Ramos A, Nascimento K, Beatriz Moretto M, Braganhol E,
Rorato Sagrillo M, Cruz L.
Pomegranate
seed oil nanoemulsions with selective antiglioma activity:
optimization and evaluation of cytotoxicity, genotoxicity and
oxidative effects on mononuclear cells.
Pharm
Biol. 2016 Jun 29, 2016:1-10, 2016;54(12):2968-2977→.
doi: 10.1080/13880209.2016.1199039→.
PMID: 27357525→.
Laboratory investigation. ˍ
|
|
|
|
Harrabi
SB, Bougatf N, Mohr A, Haberer T, Herfarth K, Combs SE, Debus J,
Adeberg S.
Dosimetric
advantages of proton therapy over conventional radiotherapy with
photons in young patients and adults with low-grade
glioma.
Strahlenther
Onkol. 2016 Jun 30, 2016;192(11):759-769→.
doi: 10.1007/s00066-016-1005-9→.
PMID: 27363701→.
Observational study. ˍ
|
|
|
|
|
|
|
|
|
